Uridine adenosine tetraphosphate
Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and possibly through the P2Y2 and P2Y4 receptors. Uridine adenosine tetraphosphate can be used in the study of cardiovascular diseases[1].
Product Specifications
CAS Number
10527-48-7
Product Name Alternative
UP4A
UNSPSC
12352005
Target
P2X Receptor
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Cardiovascular Disease
Smiles
O[C@H]1[C@@H](O)[C@H](N(C=N2)C3=C2C(N)=NC=N3)O[C@@H]1COP(OP(OP(OP(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H](N5C=CC(NC5=O)=O)O4)(O)=O)(O)=O)(O)=O)(O)=O
Molecular Formula
C19H27N7O21P4
Molecular Weight
813.35
References & Citations
[1]Jankowski, et al. "Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor." Nature medicine 11.2 (2005) : 223-227.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF740 conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF647 conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
Fibronectin (HFN7.1), CF488A conjugate, 0.1mg/mL
